A ROS-responsive nanozyme delivering gallic acid synergistically ameliorates chronic rhinosinusitis via epithelial barrier restoration and Syk/NF-κB inhibition
{{output}}
Background: Chronic rhinosinusitis (CRS) is a prevalent inflammatory disorder characterized by persistent mucosal inflammation and epithelial barrier dysfunction. However, effective therapeutic strategies targeting this core path... ...
